Kevin Albery
Lilia Aryan
Gustaf Backemar
Gesche Basile
Anja Bickelmaier
Daniel Björklund
Fabian Braemisch
James Brenner
Oliver Brook
Tom Burt
Fady Chammas
Thomas Cheung
Matthew Couch
Matthew Crill
Gani Diwan
Joachim Espen
Stephan Förschle
Per Frankling
Michael Gahleitner
Beata Gawarecka-Green
Moritz Gudenus
Claus von Hermann
Chrysanth Herr
Alice Hillson
Hans Petter Hjellestad
Thomas Hofvenstam
Martin Huth
Vyas Iyer
Sachin Jivanji
Alex Jones
Ruth Kleckow
Andi Klein
Thibaut Large
Pierre-Alexandre Lechantre
Koos van de Linde
Joakim Lindström-Formicola
Nick Mashru
Frank McNeaney
Nadia Meier-Kirner
Mike Mellody
Melanie Mitchell
Dylan Mogil
Moana Moore
Beatrice Morandi
Patrick Muûls
Besh Ocampo-Garcia
Cian O'Riordain
Amyn Pesnani
Jan Pomoell
Peder Prahl
Daisy Raven
Steffen Reimund
Peter Schwanitz
Rose Scotton
Anna Stepins
Jennifer Suman
Michael Thanner
Henrik Tholander
Cenk Turkinan
Matthew Turner
Ulrich Witt
Julia Yang
Shawn Yong
Craig Young
Friedrich Ysenburg
Yu Zhang
Tom Burt
Investment Advisory Professional - Healthcare
Tom joined Triton in 2023 from Sofinnova Partners, where he was Partner and focused on late-stage investment in EU healthcare and life sciences. He started his career in GlaxoSmithKline as a Research Engineer. Tom holds an Engineering Doctorate in Biochemical Engineering and Bioprocess Leadership from University College London, a MSc. in Biochemical Engineering from University of Birmingham, and a degree in Biotechnology from University of Leeds.